sales@scalarmarketresearch.com |  +1-800-213-5170  (U.S./ Canada Toll-free) |  REGISTER |  SIGN IN

Home >> Reports >> hiv aids diagnostics market

report

HIV/AIDS Diagnostics Market, by Product (Kits and Reagents and Instruments, Other) Test Type (Rapid Tests (POC), ELISA, Nucleic Acid Tests, Others), End user (Hospitals, Private Diagnostics Laboratories, Academic and Research Institutes, Others) – Global Revenue, Trends, Growth, Share, Size and Forecast to 2022

HC366 September 2017 100+ FREE 10% CUSTOMIZATION

A chronic disease named HIV-AIDS is caused by HIV virus. Due to this virus, human immune system is damaged as a result of which immune system becomes weak and their ability of fighting with organism is lost causing disease. Most often, HIV-AIDS is caused through unprotected sex with the person having HIV infection. Additionally, HIV-AIDS can be also be caused through HIV infected mother to child at the time of pregnancy, and also sharing needles as well as infected blood among people infected with HIV-AIDS. Few symptoms of HIV include swollen glands, headaches, slight fever, muscle aches, and fatigue. 

The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the HIV/AIDS diagnostics market. The scope of this report covers the HIV/AIDS diagnostics market by its major segments, which include the types, applications, and the major geographic regions.

KEY BENEFITS OF THE REPORT

  • In-depth analysis of the market ecosystem and its impact on the revenue growth
  • Understanding of the strategies that are being adopted by the key players in this market to stay competitive
  • Valuable insights into the key technological and market trends impacting this market

KEY PREMIUM INDUSTRY INSIGHTS

  • Growing no. of HIV patients, latest technology based advancement in the diagnosis of HIV-AIDS, escalating infectious diseases incidences; growing research activities in developing vaccines for HIV and lack of awareness associated with the transaction modes of the virus are anticipated to boost the market growth of HIV-AIDS diagnostics.
  • Additionally, HIV-AIDS can be also be caused through HIV infected mother to child at the time of pregnancy, and also sharing needles as well as infected blood among people infected with HIV-AIDS.  However, quick replacement of HIV-AIDS therapies and drugs by newer drugs as well as loss of patient protection are few restraining factors of the global market for HIV-AIDS diagnostics.

Regionally, the global HIV/AIDS diagnostics market is classified into North America, Europe, Asia-Pacific, and the Rest of the World. Among these regions, Europe, followed by North America is the leading in the global market for HIV-AIDS diagnostics owing to accessibility and affordability of costly tests done for HIV-AIDS as well as growing innovations in various therapies of drug in the region. Asia is anticipated to observe high growth rate in the global market of HIV-AIDS diagnostics over the forecast period.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s HIV/AIDS diagnostics market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the HIV/AIDS diagnostics market by the following segments:

  • HIV/AIDS Diagnostics Market, by Product Type
    • Kits and Reagents
    • Instruments
    • Others
  • HIV/AIDS Diagnostics Market, by Test Type
    • Rapid Tests (POC)
    • ELISA
    • Nucleic Acid Tests
    • Others
  • HIV/AIDS Diagnostics Market, by End Users
    • Hospitals
    • Private Diagnostics Laboratories
    • Academic and Research Institutes
    • Others

KEY MARKET PLAYERS

Key players in the HIV/AIDS diagnostics market include:

  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • Alere, Inc.
  • Bio-Rad Laboratories
  • Abbott Laboratories
  • Siemens Healthineers
  • OraSure Technologies, Inc.
  • Chembio Diagnostic Systems
  • Danaher Corporation (Cepheid)         
  • Becton, Dickinson and Company

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

  • NORTH AMERICA
    • U.S.
    • Rest of North America
  • EUROPE
    • France
    • Germany
    • U.K
    • Rest of Europe
  • ASIA-PACIFIC
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • REST OF THE WORLD
    • Latin America
    • Middle East & Africa

TRENDING RELATED REPORT

Molecular Diagnostics Market, by Products (Reagents, Consumables, Instruments, Systems), Technologies (PCR, INAAT, Microarrays, Immunochemical, Sequencing), Applications (Infectious Diseases, Oncology, Genetic Testing, Blood Screening, Microbiology) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022


  1. MARKET OVERVIEW
    1. Market Definitions
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Premium Industry Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
  5. HIV/AIDS DIAGNOSTICS MARKET, BY PRODUCT TYPE
    1. Segment share
    2. By Product Type
      1. Kits and Reagents
      2. Instruments
      3. Others
  6. HIV/AIDS DIAGNOSTICS MARKET, BY TEST TYPE
    1. Segment Share
    2. By Test Type
      1. Rapid Tests (POC)
      2. ELISA
      3. Nucleic Acid Tests
      4. Others
  7. HIV/AIDS DIAGNOSTICS MARKET, BY END USERS
    1. Segment Share
    2. By End User
      1. Hospitals
      2. Private Diagnostics Laboratories
      3. Academic and Research Institutes
      4. Others
  8. HIV/AIDS DIAGNOSTICS MARKET, BY GEOGRAPHY
    1. Segment Share
    2. North America
      1. By Regions
        1. U.S.
        2. Rest of North America
      2. By Product Type
      3. By Test Type
      4. By End User
    3. Europe
      1. By Regions
        1. France
        2. Germany
        3. U.K.
        4. Rest of Europe
      2. By Product Type
      3. By Test Type
      4. By End User
    4. Asia-Pacific
      1. By Regions
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Product Type
      3. By Test Type
      4. By End User
    5. Rest of the World
      1. By Regions
        1. Latin America
        2. Middle East & Africa
      2. By Product Type
      3. By Test Type
      4. By End User
  9. COMPETITIVE LANDSCAPE
    1. Market Positioning of Key Players, 2016
  10. KEY MARKET PLAYERS
    1. F. Hoffmann-La Roche Ltd.
      1. Overview
      2. Key Strategies
      3. Key Developments
    2. Hologic, Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    3. Alere, Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    4. Bio-Rad Laboratories
      1. Overview
      2. Key Strategies
      3. Key Developments
    5. Abbott Laboratories
      1. Overview
      2. Key Strategies
      3. Key Developments
    6. Siemens Healthineers
      1. Overview
      2. Key Strategies
      3. Key Developments
    7. OraSure Technologies, Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    8. Chembio Diagnostic Systems
      1. Overview
      2. Key Strategies
      3. Key Developments
    9. Danaher Corporation (Cepheid)
      1. Overview
      2. Key Strategies
      3. Key Developments        
    10. Becton, Dickinson and Company
      1. Overview
      2. Key Strategies
      3. Key Developments
  11. SCALAR 360 DEGREE MARKET PERSPECTIVE
  12. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170

EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

Unparalleled Expertise

Our industry experts hold inimitable know-how across wide range of industry verticals

Assured Quality

We deliver high-quality, real-time and data-driven industry insights to our clients

24x7 Analyst Support

We offer pre-purchase and post-purchase support from our industry experts

Privacy & Security

All your personal information and confidential details are safe and secure with us